Page 47 - 2019食藥署年報(英文版)
P. 47

RI GHFODUDWLRQ LQIRUPDWLRQ LQ WKH QDWLRQDO KHDOWK LQVXUDQFH  DVVLVW LQ WKH ÀRZ FRQWURO RI
                            SUHVFULSWLRQ PHGLFLQDO SURGXFWV  DQG VWUHQJWKHQ WKH SKDUPDFHXWLFDO ¿UPV¶ PDQDJHPHQW
                            RI PHGLFLQDO SURGXFWV ÀRZ

                         3FJOGPSDF UIF ESVH TBGFUZ SFBTTFTTNFOU

                         TFDA has established an active information monitoring mechanism for drug safety,
                     to instantly monitor new risks of drugs, conduct analysis and safety reassessment through a

                     notification system of adverse drug reaction, a safety monitoring system of new drugs, and
                     proactive monitoring of domestic and internal drug safety warning information. TFDA also
                     takes relevant risk management and control measures, such as issuance of warnings and
                     PRGL¿FDWLRQ RI PHGLFDWLRQ SDFNDJH LQVHUW  WR HQVXUH WKH VDIHW\ RI GUXJV

                         &TUBCMJTINFOU PG ESVH JOGPSNBUJPO QMBUGPSN

                         In the past few years, TFDA has established an online drug consultation database and

                     information platform for pharmacists and assistant pharmacists in the clinics and community
                     pharmacies to provide basic inquire about drug-related information and consultation services to
                     patients and health professionals. The platform contains information on drug dosages, adverse
                     reactions, recommendations for pregnancy and breastfeeding medications, and assessment
                     of drug interactions and duplication medicine. In addition, the Chinese version of the health
                     education leaflet is also provided by QR code. If users forget the content reminded by the
                     SKDUPDFLVW  WKH\ FDQ VFDQ WKH 45 FRGH WR RSHQ OHDÀHW DQG UHFDOO LW DW DQ\ WLPH  WKDW KHOS SDWLHQW
                     take medicines safely.



                     0VUDPNFT BOE #FOFGJUTVUDPNFT BOE #FOFGJUT
                     0
                        *NQSPWFNFOU PG UIF USBDF BOE USBDL TZTUFN PG NFEJDJOBM QSPEVDUT

                         7)'$ FUHDWHG D WUDFH DQG WUDFN RI GUXJ GHFODUDWLRQ DUHD RQ LWV RI¿FLDO ZHEVLWH  WR SURYLGH
                     D WHDFKLQJ EULH¿QJ RI GHFODUDWLRQ  FRPPRQ 4$ VHVVLRQ DQG D GHGLFDWHG SKRQH OLQH  DV ZHOO DV WR
                     provide business operators with declaration and counseling services. In 2018, we offered a total

                     count of 1,495 counseling services; conducted six communication sessions with the industries
                     and health education trainings in 2018, with a total of 233 participants. Besides, TFDA actively
                     tutored 142 business operators to successfully complete the declaring operations. Through
                     the trace and track of drug declaration, the central government cooperated with the local
                     government health bureaus in 2018 to check the drug batch number, check the validity period,
                     FKHFN WKH ÀRZ  DQG IROORZ XS DQG DUUDQJH RQ VLWH LQVSHFWLRQ ZLWK WKH +HDOWK %XUHDX WR HQVXUH
                     the legal supply of drugs.





                                                                                                           45
   42   43   44   45   46   47   48   49   50   51   52